Semi-Annual Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7720498

Concept As at
2018-05-31
2017-06-01 to
2018-05-31
2016-06-01 to
2017-05-31
As at
2017-05-31
As at
2016-05-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
7,045,387,000 JPY
5,456,743,000 JPY
Interest and dividends received
66,885,000 JPY
67,192,000 JPY
Interest paid
-23,949,000 JPY
-28,485,000 JPY
Income taxes paid
-1,678,180,000 JPY
-767,146,000 JPY
Net cash provided by (used in) operating activities
5,465,342,000 JPY
5,069,743,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,822,055,000 JPY
-2,992,150,000 JPY
Proceeds from sale of property, plant and equipment
68,828,000 JPY
JPY
Purchase of investment securities
-12,500,000 JPY
JPY
Other, net
-15,756,000 JPY
-19,677,000 JPY
Net cash provided by (used in) investing activities
-3,833,093,000 JPY
-3,011,827,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
2,500,000,000 JPY
2,300,000,000 JPY
Repayments of long-term borrowings
-2,265,333,000 JPY
-2,335,465,000 JPY
Purchase of treasury shares
-1,033,000 JPY
-670,000 JPY
Dividends paid
-412,561,000 JPY
-375,259,000 JPY
Net cash provided by (used in) financing activities
-1,543,585,000 JPY
-1,777,711,000 JPY
Effect of exchange rate change on cash and cash equivalents
5,448,000 JPY
-14,002,000 JPY
Net increase (decrease) in cash and cash equivalents
94,112,000 JPY
266,201,000 JPY
Cash and cash equivalents
1,711,449,000 JPY
1,617,337,000 JPY
1,351,135,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.